Page last updated: 2024-08-16

sulfisoxazole and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

sulfisoxazole has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grundfast, KM; Schwartz, DM; Schwartz, RH1

Other Studies

1 other study(ies) available for sulfisoxazole and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Intranasal beclomethasone in the treatment of middle ear effusion: a pilot study.
    Annals of allergy, 1980, Volume: 45, Issue:5

    Topics: Administration, Intranasal; Beclomethasone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Hypersensitivity; Infant; Male; Otitis Media; Sulfisoxazole; Time Factors

1980